Literature DB >> 14503054

[Clinical study on post-operative metastasis prevention of progressive stage of gastric cancer by weichang'an].

Jin-kun Yang1, Jian Zhen, Ke-ping Shen.   

Abstract

OBJECTIVE: To observe the effect of Weichang'an (WCA, a Chinese preparation) in preventing post-operative metastasis of progressive stage of gastric cancer.
METHODS: A prospective randomized, controlled study was conducted by dividing the 148 patients of progressive staged gastric cancer after radical operation into the WCA group, the chemotherapy (CT) group and the WCA + CT group, to observe the survival rate, metastasis rate, quality of life (QOF) and tumor-bearing survival time after relapse (TST) in patients.
RESULTS: The 1-, 2- and 3-year survival rate after operation in the WCA + CT group was 89.51%, 69.77% and 55.76% respectively, which was significantly higher than that in the CT group (83.86%, 59.33% and 49.43%) respectively (P < 0.05), but showed insignificant difference as compared with that in the WCA group (93.23%, 79.34% and 71.78%). Only 1-year metastasis in the WCA group was 15.25%, and in the WCA + CT group was 15.52%, the two were significantly lower than that in the CT group (35.48%, P < 0.05). But the comparison of 2-year metastasis rate among the 3 groups (28.81%, 41.38% and 45.16%) and 3-year metastasis rate among them (33.90%, 46.55% and 51.61%) were insignificantly different. The QOF and TST were markedly better in the WCA group than those in the CT group.
CONCLUSION: WCA has preventive effect on relapse and metastasis in post-operational gastric cancer patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14503054

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  3 in total

Review 1.  General survey of traditional Chinese medicine and Western medicine researches on tumor metastasis.

Authors:  Yong-he He
Journal:  Chin J Integr Med       Date:  2006-03       Impact factor: 1.978

2.  Effects of Wei Chang An on expression of multiple genes in human gastric cancer grafted onto nude mice.

Authors:  Ai-Guang Zhao; Ting Li; Sheng-Fu You; Hai-Lei Zhao; Ying Gu; Lai-Di Tang; Jin-Kun Yang
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

Review 3.  Benefit of Adjuvant Traditional Herbal Medicine With Chemotherapy for Resectable Gastric Cancer.

Authors:  Yu Kyung Lee; Kyeore Bae; Hwa-Seung Yoo; Seung-Hun Cho
Journal:  Integr Cancer Ther       Date:  2018-04-03       Impact factor: 3.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.